Replies to post #71641 on Amarin Corp Plc (AMRN)

[Whalatane]

Gabor will try and be clear .

I have previously listed reasons why I expect the event rate to be lower then expected in both arms .

I also believe the event rate in the V plus statin arm will be less then the placebo ( statin only ) arm .

Bottom line .. early shallow separation of event lines ( for reasons I've previously listed ) causing a slower the expected climb to the 967th event with not enough separation at that time ( 967th event ) to warrant the trial being stopped for benefit.

JMO
Kiwi